Document Detail

Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
MedLine Citation:
PMID:  19105094     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Patients with advanced coronary artery disease (CAD) have an unfovourable prognosis. Therefore, early identification of this high-risk group is important. AIM: To asses the utility of clinical, electrographic and echocardiographic parameters, supported by novel atherogenesis markers, to identify patients with triple vessel coronary artery disease (CAD). METHODS: The study group comprised 37 patients (29 males, mean age 64+/-8 years) suffering from multivessel CAD and a control group of 16 patients (8 males, mean age 60+/-10 years), in whom - despite typical stenocardial symptoms, positive exercise stress test and segmental contractility disturbances - coronary angiography did not reveal any haemodynamically significant CAD. Apart from coronary angiography, each patient had additionally an entire test panel performed assessing both the disease severity and the presence of other systemic dysfunction. Mean Gensini score in the study group was 91.9+/-43.8, including proximal Gensini score 52.6+/-45.6 and distal one 39.4+/-29.7. RESULTS: Patients with triple vessel disease had a long history of angina (mean 84 months), of whom 30 (81%) experienced at least Q-wave myocardial infarction (MI). ECG changes typical for ischaemia were observed more often than in the control group. Also in patients with triple vessel disease echocardiography showed more escalated segmental contractility disorders, and left ventricular ejection fraction in this group was significantly lower than in the control group (44 vs. 55%, p <0.001). There were significant differences between CAD patients and control groups with respect to serum levels of: adiponectin (10.5+/-4.2 vs. 17.6+/-3 microg/ml, p=0.001), resistin (13.7+/-6.1 vs. 7.2+/-2.4 ng/ml, p=0.007), TNF-alpha (4.2+/-2.9 vs. 2.1+/-1.1 pg/ml, p=0.02) and IL-8 (18.4+/-4.1 vs. 12.2+/-4.1 pg/ml, p=0.008). Significant differences were also noted in lipid profile (total cholesterol: 201+/-47.1 vs. 183+/-18 mg/dl, NS; HDL cholesterol: 45+/-8.5 vs. 54+/-11 mg/dl, p=0.005; LDL cholesterol: 126.1+/-46.9 vs. 102+/-29 mg/dl, p=0.004), NT-proBNP [516 (174-1426) vs. 187 (39-573) pg/ml, p=0.02] and fasting blood glucose levels (97+/-14 vs. 94+/-11 mg/dl, p=0.03). Significantly lower serum adiponectin levels were observed in men and tobacco smokers. CONCLUSIONS: Medical history, supported by interpretation of selected, routine imaging studies and novel biochemical markers, such as adiponectin, resistin, TNF-alpha, IL-8 or NT-proBNP, seem to be the key factors when assessing the risk of presence of advanced coronary artery atherosclerosis.
Radosław Krecki; Jarosław Drozdz; Piotr Szcześniak; Daria Orszulak-Michalak; Maria Krzemińska-Pakuła
Related Documents :
15135254 - The -344t>c promoter variant of the gene for aldosterone synthase (cyp11b2) is not asso...
1421354 - Clinical evaluation of 99mtc-mibi myocardial tomography for detecting coronary artery d...
19956784 - Association of variation in the chromosome 9p21 locus with myocardial infarction versus...
19545234 - Gender differences in ischemic heart disease.
15119504 - Electrocardiographic features in critical pulmonary embolism. results from baseline and...
8011564 - Diuretics in postinfarction heart failure.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Kardiologia polska     Volume:  66     ISSN:  0022-9032     ISO Abbreviation:  Kardiol Pol     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-12-23     Completed Date:  2009-03-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376352     Medline TA:  Kardiol Pol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  1173-80; discussion 1181-2     Citation Subset:  IM    
2nd Chair and Department of Cardiology, Medical University, Lotz, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adiponectin / blood
Biological Markers / blood*
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Coronary Angiography
Coronary Artery Disease / blood*,  diagnosis*,  epidemiology
Interleukin-8 / blood
Middle Aged
Natriuretic Peptide, Brain / blood
Peptide Fragments / blood
Resistin / blood
Smoking / blood,  epidemiology
Tumor Necrosis Factor-alpha / blood
Reg. No./Substance:
0/Adiponectin; 0/Biological Markers; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Interleukin-8; 0/Peptide Fragments; 0/Resistin; 0/Tumor Necrosis Factor-alpha; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute coronary syndrome--how to reduce the time from the onset of chest pain to treatment?
Next Document:  Heart rate turbulence in patients with chronic heart failure.